Abstract
A novel drug delivery system, enabling an in situ, thermally triggered drug release is described, consisting of an injectable thermoresponsive chitosan hydrogel containing doxorubicin-loaded thermosensitive liposomes. The design, fabrication, characterization, and an assessment of in vitro bioactivity of this formulation is detailed. Combining on-demand drug delivery with in situ gelation results in a promising candidate for local chemotherapy
| Original language | Undefined |
|---|---|
| Pages (from-to) | 854-859 |
| Journal | Advanced healthcare materials |
| Volume | 3 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- METIS-309473
- IR-95144
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver